
Dihydroergotamine Mesylate Nasal Spray is FDA-approved as therapeutic equivalent to Migranal.

Dihydroergotamine Mesylate Nasal Spray is FDA-approved as therapeutic equivalent to Migranal.

IVLBCL is a rare subtype of lymphoma that is particularly hard to diagnose due to a lack of swelling or enlargement of the lymph nodes.

Investigators found that less than a quarter of study participants with colorectal cancer were taking their medications as prescribed, suggesting that many could benefit from improved adherence.

There has been more attention been paid to the pulmonary complications of COVID-19, with less attention being paid to the cardiovascular complications that can result in death or impairment.

Critical care drug products are being introduced in the United States to help ease shortages due to the COVID-19 pandemic.

The coronavirus disease 2019 (COVID-19) pandemic has caused a disruption in daily routines, including shifts in work and home life and uncertainty for the near future.

The combination of imipenem-cilastatin and relebactam was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.

Studies pertaining to polypharmacy have been increasing over the last decade—yet, interventions aimed to prevent and manage polypharmacy are limited.

Today, we’re celebrating Dennis Heuer, PharmD, director of pharmacy at IV Solutions LLC in Wood Dale, Illinois.

What is the best-selling drug of all time?

Flip the Pharmacy helps pharmacy teams provide enhanced clinical services for their patients and has developed a COVID-19 best practices program.

Top news of the week from Pharmacy Times®.

According to a recent study, olanzapine may help patients with advanced cancer manage symptoms unrelated to chemotherapy, such as nausea and vomiting.

Specialty pharmacy is beginning to implement its own set of strategies in order to manage the cost of one of the most expensive sectors of the pharmaceutical industry.

What characteristics of RA treatments possibly connect to COVID-19 treatment?

The US Senate recently passed the Paycheck Protection Program Flexibility Act after its quick success in the House last week.

Including medication disposal methods with prescriptions could reduce opioid diversion and childhood poisonings.

Today, we’re celebrating the work of everyone at Boone Drugs Inc in North Carolina.

Amid ongoing protests across the country, pharmacy staff and owners are seeking ways to stay safe and avoid damage or looting.

The study contributes to a growing body of research suggesting that fitness has beneficial effects for brain health, applying magnetic resonance spectroscopy to detect and measure brain metabolites, focusing specifically on N-acetyl aspartic acid (NAA).

Technicians and pharmacists both agreed that the Optimizing Care Model allowed the pharmacy to implement entirely new services and expand the number of patients who were receiving existing services.

Today, we’re celebrating the work of Sam Ibrahim, PharmD, from Carepoint Healthcare in Schaumburg, Illinois.

Business planning includes many components, not just merely generating an idea and hoping it will succeed.

Telemedicine and connected devices are emerging as technologies to provide greater access and convenience to care for those who can defer treatment by way of an in-person consultation.

Sub-optimally managed pain is the outcome of a reactionary position to the opioid epidemic.

HIV drug prices rose 34% between 2012 and 2018 and continue to climb, which experts say is a huge issue.

According to a new survey released by the NCPA, COVID-19 is changing how local pharmacies do business across the country, and these changes may be for the long term.

It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic.

The recommended dosage of lemborexant CIV is one 5 mg tablet taken no more than once per night, immediately before going to bed with at least 7 hours remaining before the planned time of awakening.

This marks the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in patients with a high cardiovascular risk but without a history of heart attack or stroke.